Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade-Reference-Cited by-同舟云学术

Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Greco Rita¹,Qu Hongjing¹,Qu Hui²,Theilhaber Joachim³,Shapiro Gary¹,Gregory Richard¹,Winter Christopher¹,Malkova Natalia²,Sun Frank²,Jaworski Julie⁴,Best Annie⁴,Pao Lily¹,Hebert Andrew⁵,Levit Mikhail⁵,Protopopov Alexei³,Pollard Jack³,Bahjat Keith¹,Wiederschain Dmitri¹,Sharma Sharad¹^ORCID

Affiliation:

1. Immuno-Oncology Research, Sanofi, 640 memorial drive, Cambridge

2. Oncology In Vivo Pharmacology, Sanofi, 640 memorial drive, Cambridge

3. Precision Oncology, Sanofi, 270 albany street, Cambridge

4. Biologics Research, Sanofi, 49 New York Ave, Framingham

5. Translational Sciences, Sanofi, Cambridge, MA, US

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1811605